# Starling Oncology expects $650M-$660M revenue and $4M-$6M adjusted EBITDA in 2026 while targeting 100% capitated revenue growth in 2027

- Source: Seeking Alpha Market Currents
- Published: 2026-11-06T16:55:57+00:00
- Category: Markets
- Original: https://seekingalpha.com/news/4668368-starling-oncology-expects-650m-660m-revenue-and-4m-6m-adjusted-ebitda-in-2026-while-targeting?utm_source=feed_news_all&utm_medium=referral&feed_item_type=news
- Canonical: https://groundlevelnews.com/story/starling-oncology-expects-650m-660m-revenue-and-4m-6m-adjusted-ebitda--da2d13/

Read the full report from the original publisher.

_Ground Level News shows a short summary only; the full article and all rights belong to Seeking Alpha Market Currents._